Every medicine on a pharmacy shelf carries an expiry date, and every expiry date must be supported by stability data. For exporters, stability is one of the most technical parts of the registration dossier and one of the most common sources of regulator queries. A product that is perfectly stable in a temperate climate may degrade faster in a hot and humid one, which is why regulators ask for data generated under conditions that reflect their own climate.
This guide explains the ICH climatic zone system, the storage conditions used for testing, and how to design a stability programme that supports registrations across multiple export markets.
What a Stability Study Proves
A stability study shows how the quality of a drug product changes over time under the influence of temperature, humidity and light. The results are used to set the shelf life, define storage instructions such as “Store below 30°C”, and confirm that the chosen packaging protects the product adequately.
The core international reference is the ICH Q1A(R2) guideline on stability testing of new drug substances and products, supported by related guidance on photostability and on bracketing and matrixing designs. The WHO has published its own stability guideline that many emerging market regulators follow.
The Climatic Zones Explained
The world is divided into climatic zones based on average temperature and humidity. Long term stability conditions are chosen to represent the zone where the product will be marketed.
| Zone | Climate | Typical long term condition |
|---|---|---|
| Zone I | Temperate | 21°C / 45% RH |
| Zone II | Subtropical and Mediterranean | 25°C / 60% RH |
| Zone III | Hot and dry | 30°C / 35% RH |
| Zone IVa | Hot and humid | 30°C / 65% RH |
| Zone IVb | Hot and very humid | 30°C / 75% RH |
Many markets that Indian exporters serve, including much of Southeast Asia, several African regulatory regions and Brazil, expect data at Zone IVb conditions. Because 30°C / 75% RH is the most demanding long term condition, a product proven stable at IVb is usually acceptable in less demanding zones as well, which makes IVb a smart default for a global master dossier.
Types of Stability Studies
Long Term Studies
Long term studies run at the zone specific condition for the full proposed shelf life. Samples are typically tested every three months in the first year, every six months in the second year and annually after that.
Accelerated Studies
Accelerated studies use stressed conditions, commonly 40°C / 75% RH for six months, to predict long term behaviour and detect potential problems early. Significant change under accelerated conditions triggers testing at an intermediate condition.
Intermediate Studies
Where the long term condition is 25°C / 60% RH and significant change occurs during accelerated testing, an intermediate study at 30°C / 65% RH is added.
Other Studies
- Photostability to assess sensitivity to light and justify light protective packaging
- In-use stability for multi dose products such as syrups and eye drops after opening
- Reconstitution stability for dry syrups and powders for injection
- Ongoing stability on commercial batches, usually at least one batch per year
Designing a Stability Programme Regulators Accept
- Define the target markets first. Map every intended country to its climatic zone and specific national requirements.
- Use representative batches. Registration generally expects data on at least three primary batches, at least two of them at pilot scale or larger, made by a process representative of commercial production.
- Test in the final packaging. The container closure system used in the study must match what will be marketed. A cheaper blister foil later on may need new data.
- Use validated, stability indicating methods. Assay and impurity methods must be able to detect degradation products.
- Plan the data timeline. Many authorities expect a minimum of twelve months long term and six months accelerated data at submission, though some accept less with a commitment to continue. Confirm the requirement for each country.
- Commit to ongoing studies. Include a post approval stability commitment in the dossier and follow it.
The cheapest stability study is the one you only run once. Designing for Zone IVb and the strictest target market from the start avoids repeating years of testing later.
Common Pitfalls and How to Avoid Them
- Packaging changes after the study starts. Lock the pack before loading batches.
- Humidity sensitive products in permeable packs. Consider Alu-Alu blisters or desiccants for moisture sensitive formulations.
- Unexplained out of trend results. Investigate and document them. Regulators focus on trends, not only on results within limits.
- Chamber qualification gaps. Stability chambers must be qualified, mapped and continuously monitored with alarm records available for review.
Using Stability Data to Set Shelf Life
Shelf life is assigned by evaluating the trend of each critical attribute, such as assay, degradation products, dissolution and water content, against its acceptance criteria. Where data shows little change, limited extrapolation beyond the real time data may be acceptable under ICH principles, supported by accelerated results. Where there is clear degradation, statistical analysis of the long term data is used to estimate the time at which the attribute would cross its limit.
Always align label storage statements with the data. A product tested only at 25°C / 60% RH cannot carry a “Store below 30°C” statement for a Zone IVb market, and regulators will ask for supporting data or a more restrictive label.
Managing Stability Across a Portfolio
Companies with many products and markets benefit from a stability master plan. It lists every product, pack, strength and market, the studies required, their start dates and pull points, and the resulting data commitments made in dossiers. Bracketing and matrixing designs, when justified, can reduce testing load for multiple strengths or pack sizes without weakening the scientific basis of the shelf life.
Choose your climatic zone strategy before development batches are made. A well designed Zone IVb programme on commercial packaging gives you one stability package that supports registrations across most emerging markets.
How Zanax Healthcare Can Help
Our R&D and regulatory teams design stability protocols around your target markets, coordinate studies in qualified ICH chambers and compile the stability section of your CTD dossier. Contact us to plan a stability strategy for your next product.
